Today, the National Institute for Health and Care Excellence (NICE) have given approval for the life-changing cystic fibrosis modulator drugs – Kaftrio, Symkevi and Orkambi - to be made available on the NHS in England. This follows many years of campaigning by Cystic Fibrosis Trust and people right across the CF community. This is a really significant moment as it offers certainty and hope to thousands of people affected by CF, a life-long, life-limiting condition without a cure. Head to our web